Clinical Trial Update: Study of Aripiprazole in the Treatment of Patients With Acute Symptoms in Bipolar Disorder [Phase 3]

View source ↗

Summary

A Phase 3 trial of aripiprazole for acute symptoms in bipolar disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• ARIPIPRAZOLE (Aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED